GoodRx Holdings, Inc. — Director's Dealing 2021

Sep 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-09-24

Reporting Person: Bezdek Trevor (Director, Co-CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-24	Class A Common Stock	S	116558	$44.2365	Disposed	143784	Direct
2021-09-24	Class A Common Stock	S	6912	$45.2371	Disposed	136872	Direct
2021-09-24	Class A Common Stock	S	900	$46.1004	Disposed	135972	Direct
2021-09-27	Class A Common Stock	S	4604	$42.951	Disposed	131368	Direct
2021-09-27	Class A Common Stock	S	400	$43.5825	Disposed	130968	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2020.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.87 to $44.85, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: Prior to the reported transaction, the Reporting Person held 260,342 shares of Class A Common Stock, rather than 391,408 shares of Class A Common Stock. The Reporting Person's prior Form 4 inadvertently included 131,066 shares that had been sold on March 22, 2021 and reported in a Form 4 filed on March 24, 2021.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.87 to $45.77, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.89 to $46.36, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.44 to $43.38, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.47 to $43.73, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.